While LLMs dominate headlines, Dr. Fei-Fei Li argues that "spatial intelligence"—the ability to understand and interact with the 3D world—is the critical, underappreciated next step for AI. This capability is the linchpin for unlocking meaningful advances in robotics, design, and manufacturing.

Unlike text-based LLMs where simply increasing parameter count works, Verge Labs found the biggest AI performance gains in biology come from scaling data modalities—adding new types of data like proteomics and imaging. Fusing different data sources is more critical than just making the model bigger.

A major challenge in phenotypic drug screening is determining a compound's mechanism of action. AI models can analyze the complex visual data of cellular condensates after drug treatment, extracting maximal information to understand how the drug is actually working inside the cell.

The primary obstacle to creating sophisticated AI models of cells isn't the AI itself, but the data. Existing datasets often perturb only one cellular variable at a time, failing to capture the complex interactions that arise from simultaneous changes. New platforms are needed to generate this multi-dimensional data.

Dr. Fei-Fei Li cites the deduction of DNA's double-helix structure as a prime example of a cognitive leap that required deep spatial and geometric reasoning—a feat impossible with language alone. This illustrates that future AI systems will need world-modeling capabilities to achieve similar breakthroughs and augment human scientific discovery.

The next frontier in preclinical research involves feeding multi-omics and spatial data from complex 3D cell models into AI algorithms. This synergy will enable a crucial shift from merely observing biological phenomena to accurately predicting therapeutic outcomes and patient responses.

Current multimodal models shoehorn visual data into a 1D text-based sequence. True spatial intelligence is different. It requires a native 3D/4D representation to understand a world governed by physics, not just human-generated language. This is a foundational architectural shift, not an extension of LLMs.

While acknowledging the power of Large Language Models (LLMs) for linear biological data like protein sequences, CZI's strategy recognizes that biological processes are highly multidimensional and non-linear. The organization is focused on developing new types of AI that can accurately model this complexity, moving beyond the one-dimensional, sequential nature of language-based models.

Advanced microscopes like MOSAIC produce terabytes of data per hour, but researchers take a "couple of year breather" to understand what was recorded in just days. This 100x to 10,000x analysis bottleneck highlights the urgent need for AI-driven interpretation to unlock the discoveries hidden within this data.